Just Published: "NanoIVD, Inc. - Product Pipeline Analysis, 2014 Update"
NanoIVD, Inc. (Nano) is a medical device company. The company researches, develops, and commercializes blood-based tests for cancer-recurrence monitoring, treatment-effectiveness monitoring, and personalized molecular cancer profiling for therapeutic selection. Its products include CDKN2A, GATA3, KRAS, TP53, BRAF, RB1, MLH1, HER2, HRAS, EFFR, PIK3CA, CTNNB1, APC, NF1, PTEN and FBXW7, among others. The company also has research facilities in California NanoSystems Institute at UCLA, Nanoelectronics Research Facility at UCLA, and Kavli Nanoscience Institutes at Caltech. It partners with Johns Hopkins Medical...
View full press release